Preclinical Studies of Immunogenity, Protectivity, and Safety of the Combined Vector Vaccine for Prevention of the Middle East Respiratory Syndrome

The Middle East Respiratory Syndrome (MERS) is an acute inflammatory disease of the respiratory system caused by the MERS-CoV coronavirus. The mortality rate for MERS is about 34.5%. Due to its high mortality rate, the lack of therapeutic and prophylactic agents, and the continuing threat of the spr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Acta Naturae
Hlavní autoři: Dolzhikova, I. V., Grousova, D. M., Zubkova, O. V., Tukhvatulin, A. I., Kovyrshina, A. V., Lubenets, N. L., Ozharovskaia, T. A., Popova, O., Esmagambetov, I. B., Shcheblyakov, D. V., Evgrafova, I. M., Nedorubov, A. A., Gordeichuk, I. V., Gulyaev, S. A., Botikov, A. G., Panina, L. V., Mishin, D. V., Loginova, S. Y., Borisevich, S. V., Deryabin, P. G., Naroditsky, B. S., Logunov, D. Y., Gintsburg, A. L.
Médium: Artigo
Jazyk:Inglês
Vydáno: A.I. Gordeyev 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7604897/
https://ncbi.nlm.nih.gov/pubmed/33173601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.32607/actanaturae.11042
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky